News | October 24, 2013

Urologists Denounce New England Journal of Medicine Article Regarding Prostate Cancer Treatment

October 24, 2014 — Large Urology Group Practice Association (LUGPA), an organization advocating for integrated and coordinated urological care, says it has reviewed the article "Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer" (Mitchell, JM, New England Journal of Medicine 369:17, Oct. 24, 2013) and found it to be methodologically flawed and factually inaccurate and, as such, did not contribute to the useful interchange of ideas needed to improve healthcare or increase value.

"The Mitchell study was commissioned and funded by the American Society for Radiation Oncology (ASTRO) in an attempt to persuade lawmakers to legislate a monopoly for its members in the use of radiation therapy to treat prostate cancer — an economically-driven agenda that has been rejected by Congress, MedPAC and the GAO," said Deepak Kapoor, president of LUGPA, and chairman and CEO of Integrated Medical Professionals PLLC. "Instead of furthering our understanding of the complicated health policy issues around prostate cancer care, Dr. Mitchell's work appears to be specifically designed to produce talking points for the sponsor's political agenda, which is primarily to restore their virtual monopoly on the provision of pathology laboratory services."

The data from the study by Jean Mitchell, Ph.D., economics professor at Georgetown University, stated that less than one-third of newly diagnosed prostate cancer patients who sought treatment from an integrated urology group received intensity-modulated radiation therapy (IMRT). This figure is in line with data from academic literature that predates the development of integrated groups.[1],[2] The study did not match its control group for practice size, patient demographics or severity of disease. According to Kapoor, its selection bias is evidenced by its own bizarre results. 

For example, the group says there has been a clear national trend toward less-invasive IMRT and away from brachytherapy seen nationally across all sites of service.[3][4] Paradoxically, over the six-year study period, the use of IMRT and brachytherapy remained flat in Mitchell's control group. The fact that integrated groups' rates of active surveillance and surgery held constant further illustrates that ownership of IMRT did not affect these groups' clinical decision-making. 

"Her own data confirms that urologists with ownership of radiation oncology use the technology appropriately and responsibly,” said Kapoor. “That should be the title of Mitchell's study.”

According to Kapoor, the ASTRO study serves only one purpose, to undermine competition in the marketplace, adding that utilizing such data that demonizes groups practicing evidence-based medicine in an attempt to manipulate market share by legislative fiat is both inappropriate and offensive. Legislative changes based on such data will drive up costs as many patients will be forced to seek care in the more expensive hospital setting, and harm patient access to specialized, integrated care.

Opinions expressed in this article are those of Kapoor and David Penson, M.D., professor of urologic surgery at Vanderbilt University and director of Vanderbilt Center for Surgical Quality and Outcomes Research.


[1] Nguyen PL, Gu X, Lipsitz SR, et al.  Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer. J Clin Onc. 2010; Mar; 3: 1217 

[2] Jang TL, Bekelman JE, Liu Y, et al. Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med. 2010;170(5):440-450. 

[3] Kapoor DA, Zimberg SH, Ohrin LM, et al. Utilization trends in prostate cancer therapy. J Urol. 2011 Sep;186(3):860-4. 

[4] Mahmood U, Pugh T, Frank S et al.  Declining use of brachytherapy for the treatment of prostate cancer.  Brachytherapy, in press.  Accessed at:

For more information:

Related Content

Brain Imaging Predicts Language Learning in Deaf Children
News | Magnetic Resonance Imaging (MRI) | January 23, 2018
January 23, 2018 – In a new international collaborative...
Imricor Announces Enrollment Completion for Clinical Study on Vision-MR Ablation Catheter
News | Interventional Radiology | January 23, 2018
January 23, 2018 – Imricor Medical Systems announced completion of enrollment for the...
ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Smartphone Addiction Creates Imbalance in Brain
News | Mobile Devices | January 11, 2018
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet,...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
Overlay Init